Christin Tauchmann

1 Patent

• US122081012025

  Tablet Formulation of 2-fluoro-n-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide

  NOVARTIS AG

  0 cites